Anavex Life Sciences Corporation Stockholder Alert: Robbins LLP Reminds Investors of AVXL Class ActionBusiness Wire • 03/18/24
Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in SchizophreniaGlobeNewsWire • 03/18/24
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Anavex Life Sciences Corp. and Encourages Investors with Losses to Contact the FirmAccesswire • 03/15/24
Class Action Filed Against Anavex Life Sciences Corporation (AVXL) Seeking Recovery for Investors – Contact Levi & KorsinskyAccesswire • 03/15/24
Anavex Life Sciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights – AVXLAccesswire • 03/14/24
AVXL INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Anavex Life Sciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBusiness Wire • 03/14/24
Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Ongoing Investigation into Potential Violations of Securities Laws - AVXLAccesswire • 03/13/24
Lost Money on Anavex Life Sciences Corp.(AVXL)? You May Have Been Affected by Fraud- Contact Levi & KorsinskyAccesswire • 03/12/24
Shareholders that lost money on Anavex Life Sciences Corp.(AVXL) should contact Levi & Korsinsky about Securities Fraud Investigation - AVXLAccesswire • 03/11/24
Lost Money on Anavex Life Sciences Corp.(AVXL)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire • 03/08/24
AVXL ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Anavex Life Sciences Corp.Accesswire • 03/07/24
ATTENTION Anavex Life Sciences Corp. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your RightsAccesswire • 03/06/24
Shareholder Rights Advocates at Levi & Korsinsky Investigate Anavex Life Sciences Corp. (AVXL) Regarding Possible Securities Fraud ViolationsAccesswire • 03/04/24
Anavex Life Sciences Corp. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Anavex Life Sciences (AVXL)Accesswire • 03/04/24
Did Anavex Life Sciences Corp. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- AVXLAccesswire • 02/27/24
Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care ConferenceGlobeNewsWire • 02/26/24
Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business UpdateGlobeNewsWire • 02/07/24
Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024GlobeNewsWire • 02/01/24
Wall Street Analysts Believe Anavex Life Sciences (AVXL) Could Rally 530.68%: Here's is How to TradeZacks Investment Research • 01/31/24
Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in HumansGlobeNewsWire • 01/24/24
Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in SchizophreniaGlobeNewsWire • 01/16/24
Anavex (AVXL): Strong Industry, Solid Earnings Estimate RevisionsZacks Investment Research • 01/09/24